Zobrazeno 1 - 10
of 70
pro vyhledávání: '"I. Z. Gaydukova"'
Autor:
A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 32-43 (2024)
The efficacy and safety of levilimab (LVL) in patients with active rheumatoid arthritis (RA) has been confirmed in controlled clinical trials. This article presents the results of a preliminary analysis of a non-interventional observational study of
Externí odkaz:
https://doaj.org/article/4031788a32de403ebea6e82d4f01065d
Autor:
E. L. Nasonov, V. I. Mazurov, A. M. Lila, T. V. Dubinina, I. Z. Gaydukova, S. A. Lapshina, A. A. Klimenko, D. V. Somov, S. A. Lukianov, D. M. Chudakov, I. V. Zvyagin, O. V. Britanova, M. A. Korolev, D. I. Abdulganieva, D. G. Krechikova, A. A. Kastanayan, L. V. Eliseeva, R. R. Samigullina, T. V. Povarova, O. V. Antipova, S. A. Smakotina, V. N. Soboleva, O. B. Nesmeyanova, T. V. Plaksina, N. F. Soroka, I. B. Vinogradova, A. P. Rebrov, T. V. Kropotina, A. L. Maslyanskiy, A. V. Zinkina-Orikhan, Yu. N. Lin’kova, P. S. Pukhtinskaia, M. A. Morozova, G. A. Vinderskaya
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 65-80 (2024)
The aim – to evaluate the clinical effectiveness, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of seniprutug (BCD-180) in patients with radiographic active axial spondyloarthritis (r-axSpA, or ankylosing spondylitis).Subjects and
Externí odkaz:
https://doaj.org/article/38cd433e63d04c6c9e4e85e988370a30
Autor:
S. S. Benevolenskaya, I. V. Kudriavtsev, M. K. Serebriakova, A. A. Rubinstein, E. S. Kuvardin, I. N. Grigor’yeva, D. B. Aliev, D. B. Zammoeva, D. B. Motorin, A. S. Golovkin, O. V. Kalinina, S. V. Lapin, I. Z. Gaydukova, A. L. Maslyanskiy, E. K. Gaydukova
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 90-97 (2024)
Relevance. Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immune tolerance and sustained production of autoantibodies.The aim of the study – to compare composition of peripheral blood cytotoxic CD8+ T lymphocyt
Externí odkaz:
https://doaj.org/article/620ec49b1c9e4f4dabb149a8ef66de1b
Autor:
V. I. Mazurov, Sh. F. Erdes, I. Z. Gaydukova, T. V. Dubinina, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, E. P. Ilivanova, A. V. Strelkova, V. V. Tyrenko, E. A. Mikhailova, A. V. Eremeeva
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 35-46 (2024)
The article presents the results of the three-year use of netakimab (NTK) in patients with ankylosing spondylitis (AS) as part of the phase III BCD-085-5/ASTERA study.Objective: to evaluate the long-term efficacy and safety of NTK over a three-year p
Externí odkaz:
https://doaj.org/article/35b1cb81150247aab4f58712cc2503b9
Autor:
Sh. Erdes, V. I. Mazurov, I. Z. Gaydukova, O. N. Anoshenkova, I. B. Vinogradova, Yu. Yu. Grabovetskaya, S. Yu. Davidian, O. E. Epifanova, N. A. Kiryukhina, L. V. Masneva, I. V. Menshikova, O. N. Mironenko, N. E. Nikulenkova, T. V. Povarova, A. N. Polyatika, R. R. Samigullina, A. E. Sizikov, I. N. Totrov, I. F. Umnova, J. V. Usacheva, A. L. Chudinov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 6, Pp 700-710 (2024)
Background. Netakimab has shown high efficacy in controlled clinical trials in the treatment of patients with ankylosing spondylitis (AS). This article presents results of an observational study of netakimab using in routine clinical practice.Methods
Externí odkaz:
https://doaj.org/article/7e5bc44473f34733b5ff6008d493e861
Autor:
T. V. Dubinina, A. B. Demina, E. M. Agafonova, Sh. F. Erdes, V. I. Mazurov, I. Z. Gaydukova, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, V. V. Tyrenko, E. P. Ilivanova, A. V. Strelkova
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 52-58 (2023)
The article contains the data obtained during the 156-week follow-up of patients with ankylosing spondylitis (AS) in the ASTERA phase III study.Objective: to evaluate the effect impact of netakimab (NTK) on quality of life (QoL), back pain and work c
Externí odkaz:
https://doaj.org/article/21939fb7c39048f99cdce239380dea45
Autor:
A. P. Rebrov, I. Z. Gaydukova, A. V. Aparkina, M. A. Korolev, K. N. Safarova, K. D. Dorogoikina, D. M. Bichurina
Publikováno v:
Архивъ внутренней медицины, Vol 12, Iss 4, Pp 310-315 (2022)
Background. According to the scientific literature, anti-CD74 IgA antibodies (IgA anti-CD74) are considered as a possible marker for the diagnosis of axial spondyloarthritis (SpA). The level of IgA anti-CD74 in patients with back pain due to degenera
Externí odkaz:
https://doaj.org/article/4e621b245a4c4a6a82d6ed31e0a45470
Autor:
T. V. Dubinina, I. Z. Gaydukova, N. А. Sableva, K. V. Sapozhnikov, V. D. Sokolova, D. G. Tolkacheva
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 6 (2022)
Objective – to compare the clinical efficacy and cost-effectiveness of IL-17 inhibitors (SEC, IXE, NTK) in the treatment of adult patients with ankylosing spondylitis (AS) in the healthcare system of the Russian Federation.Material and methods. The
Externí odkaz:
https://doaj.org/article/47629f636fa848c4977dbb4af409745d
Autor:
V. I. Mazurov, E. G. Zotkin, I. Z. Gaydukova, E. P. Ilivanova, T. V. Kropotina, T. V. Plaksina, O. B. Nesmeyanova, N. F. Soroka, E. A. Kunder, E. A. Dokukina, Yu. N. Linkova, N. A. Kravtsova, P. S. Pukhtinskaya, A. V. Eremeeva, A. V. Zinkina-Orikhan, A. A. Lutckii
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 2, Pp 141-151 (2021)
Levilimab (LVL) is a monoclonal antibody against the interleukin-6 receptor (IL6R). The article presents data obtained during 56 weeks of the AURORA phase II study.Objective: to evaluate the efficacy safety and immunogenicity of LVL in methotrexate (
Externí odkaz:
https://doaj.org/article/b875e4d7b7464abf86d0680266117122
Autor:
T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaydukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Zinkina-Orikhan, Yu. A. Sevastyanova, A. V. Eremeeva
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 1, Pp 47-55 (2021)
Netakimab is a humanized anti-interleukin-17А monoclonal antibody approved for the treatment of psoriatic arthritis, ankylosing spondylitis, moderate to severe psoriasis. Herein, we report the accumulated efficacy data and safety findings of 54-week
Externí odkaz:
https://doaj.org/article/4cf1afa40e2e4cf69285a9061fcc7d8f